Cage Bio Incis A Biotechnology Company Located In San Carloscaliforniafounded In 2017The Company Is Focused On Developing Therapeutic Products Using Innovative Deep Eutectic Ionic Liquid Technologyas A Clinical Stage Startupcage Bio Is Actively Engaged In The Clinical Trials Phase Of Its Product Development The Company Specializes In Three Main Therapeutic Areasdermatologyinflammationand Immunologycage Bio Aims To Create Treatments For Skin Related Conditionsmanage Inflammationand Address Immune System Disordersits Proprietary Technology Supports The Development Of Novel Formulations That Enhance The Delivery And Effectiveness Of Therapeutic Agents
